Curran has spent several years in rare disease research, obsessing over the biological problem of suffering. Previously an accomplished public and private investor.
Novel treatments for chronic pain
Chronic pain affects 1.5 billion people globally. The economic cost in the US is more than heart disease, cancer, and diabetes combined.
We’re developing therapeutics for chronic pain with less tolerance, dependence and withdrawal.
Programs in development
A portfolio of non-addictive mechanisms for chronic pain, advancing from discovery toward the clinic.
Leadership
Max is a serial entrepreneur, previously the co-founder and CEO of Worldcoin. He is passionate about translating promising clinical work into real outcomes in patients.
In 1998 David started the World Transhumanist Association with Nick Bostrom and has dedicated his life to the abolition of suffering through the development of biotechnology.
Michael is an accomplished neuroscientist researching the mechanistic basis of pain and wellbeing.
Kristian is the CEO and co-founder of Lucid Computing. He previously founded Normative, and has a background in mathematics, philosophy, computer science, and artificial intelligence.
Open roles
We're a small team building the science to end chronic pain. If that's your life's work too, we want to meet you.
Computational Chemist
Drive drug discovery through molecular dynamics and small molecule design, applying computational chemistry to advance our pipeline.
ApplyPatent Strategist
Lead IP strategy by drafting and submitting patents, and build AI agents that accelerate our patent workflow.
Apply